Search

Your search keyword '"Akter, Afroza"' showing total 142 results

Search Constraints

Start Over You searched for: Author "Akter, Afroza" Remove constraint Author: "Akter, Afroza"
142 results on '"Akter, Afroza"'

Search Results

7. Appearance of tolerance-induction and non-inflammatory SARS-CoV-2 spike-specific IgG4 antibodies after COVID-19 booster vaccinations

8. Esculetin unveiled: Decoding its anti‐tumor potential through molecular mechanisms—A comprehensive review

9. Cholera toxin and O-specific polysaccharide immune responses after oral cholera vaccination with Dukoral in different age groups of Bangladeshi participants.

13. Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial

16. A snap-shot of a diarrheal epidemic in Dhaka due to enterotoxigenic Escherichia coli and Vibrio cholerae O1 in 2022

18. Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial

20. Safety of a bivalent, killed, whole-cell oral cholera vaccine in pregnant women in Bangladesh: evidence from a randomized placebo-controlled trial

21. The Fatal Clinical Outcome of Severe COVID-19 in Hospitalized Patients: Findings from a Prospective Cohort Study in Dhaka, Bangladesh.

22. Long-term sialidase-specific immune responses after natural infection with cholera: Findings from a longitudinal cohort study in Bangladesh

23. Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh

25. PSI-1 Effects of Pre-Transit Diets and Road Transportation on Plasma, Salivary Cortisol, and Rumen Environment of Beef Heifers

26. Vibrio cholerae Isolation from Frozen Vomitus and Stool Samples

27. Correlation of antigen-specific immune response with disease severity among COVID-19 patients in Bangladesh

28. Upregulation of Activation Induced Cell Markers (AIM) among Severe COVID-19 patients in Bangladesh

30. Causes of death through verbal autopsy: findings from a sub-study of single dose oral cholera vaccination in urban Dhaka, Bangladesh

33. Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh

35. A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh

36. A Co-abundant Gene Analysis for Identification of Gut Microbial Strains Associated with Immune Responses to Oral Cholera Vaccine

38. A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh

39. Efficacy of a Single-Dose, Inactivated Oral Cholera Vaccine in Bangladesh

40. Role of Pyroptosis in Diabetes and Its Therapeutic Implications

42. A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh

44. Hematological and immunological responses to naturally occurring bovine respiratory disease in newly received beef calves in a commercial stocker farm.

45. A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh.

46. Role of NLRP3 inflammasome in liver disease

47. Immunogenicity of a killed bivalent whole cell oral cholera vaccine in forcibly displaced Myanmar nationals in Cox's Bazar, Bangladesh

48. Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine

50. Role of Pyroptosis in Diabetes and Its Therapeutic Implications.

Catalog

Books, media, physical & digital resources